J. Michael Pearson

2011 - Valeant Pharmaceuticals International

In 2011, J. Michael Pearson earned a total compensation of $36.7M as Chief Executive Officer at Valeant Pharmaceuticals International, a 672% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,996,825
Option Awards$6,015,000
Salary$1,578,462
Stock Awards$12,168,384
Other$13,951,315
Total$36,709,986

Pearson received $14M in other compensation, accounting for 38.00% of the total pay in 2011.

Pearson also received $3M in non-equity incentive plan, $6M in option awards, $1.6M in salary and $12.2M in stock awards.

Rankings

In 2011, J. Michael Pearson's compensation ranked 18th out of 10,578 executives tracked by ExecPay. In other words, Pearson earned more than 99.8% of executives.

ClassificationRankingPercentile
All
18
out of 10,578
100th
Division
Manufacturing
5
out of 3,902
100th
Major group
Chemicals And Allied Products
1
out of 978
100th
Industry group
Drugs
1
out of 739
100th
Industry
Pharmaceutical Preparations
1
out of 534
100th
Source: SEC filing on April 22, 2014.

Pearson's colleagues

We found six more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2011.

2011

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2011

Brian Stolz

Valeant Pharmaceuticals International

Executive Vice President of Administration and Chief Human Capital Officer

2011

Rajiv De Silva

Valeant Pharmaceuticals International

Chief Operating Officer

2011

Mark Durham

Valeant Pharmaceuticals International

Senior Vice President, Human Resources

2011

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2011

Philip Loberg

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like